How does cannabis compare to NSAIDs for fibromyalgia?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Finding the right fibromyalgia treatment can be a process of trial and error. For many, the choice between traditional options like NSAIDs and alternative therapies such as cannabis is part of that journey. The question often arises how does cannabis stack up against over-the-counter pain relievers?

The discussion around cannabis vs NSAIDs reflects a broader shift in how we approach pain relief, particularly for chronic and complex conditions like fibromyalgia.

Though NSAIDs are commonly used in fibromyalgia treatment, they often fall short in managing the full spectrum of symptoms. Meanwhile, cannabis is gaining traction for its broader potential benefits in pain relief and sleep support.

Comparing cannabis and NSAIDs for fibromyalgia management

Below are several key points patients and clinicians consider when comparing these options:

Mechanism of Action

NSAIDs target inflammation, which is not always the main cause of fibromyalgia pain. Cannabis, however, interacts with the endocannabinoid system to influence pain signalling and neurological symptoms.

Effectiveness

Some users report better symptom control with cannabis, particularly for sleep and mood disturbances areas where NSAIDs offer little benefit.

Side Effect Profile

While NSAIDs can cause gastrointestinal and cardiovascular issues with long-term use, cannabis may result in dizziness, dry mouth, or fatigue, depending on dosage and type.

Long-Term Use

Cannabis might be more suitable for chronic use under medical guidance, whereas prolonged NSAID use carries well-documented health risks.

Individual Preference

The decision often comes down to how each individual responds. Patients might rotate between or combine therapies based on symptom intensity and pain relief goals.

In the evolving landscape of fibromyalgia treatment, both cannabis and NSAIDs have roles to play. However, cannabis may offer additional flexibility and holistic support for those needing more than anti-inflammatory relief.

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.